[HTML][HTML] Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri… - Respiratory …, 2007 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a deadly disease, largely unresponsive to treatment
with corticosteroids and immunosuppressives. The aim of this randomized, prospective …

Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis.

EG Tzortzaki, KM Antoniou, MI Zervou… - Respiratory …, 2007 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a deadly disease, largely unresponsive to treatment
with corticosteroids and immunosuppressives. The aim of this randomized, prospective …

[引用][C] Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis

EG TZORTZAKI, KM ANTONIOU… - Respiratory …, 2007 - pascal-francis.inist.fr
Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with
idiopathic pulmonary fibrosis CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[HTML][HTML] Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou… - Respiratory …, 2007 - resmedjournal.com
Idiopathic pulmonary fibrosis (IPF) is a deadly disease, largely unresponsive to treatment
with corticosteroids and immunosuppressives. The aim of this randomized, prospective …

[引用][C] Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri… - Respiratory …, 2007 - cir.nii.ac.jp
Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with
idiopathic pulmonary fibrosis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[PDF][PDF] Effects of antifibrotic agents on TGF-b1, CTGF and IFN-c expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri… - Respiratory …, 2007 - core.ac.uk
Idiopathic pulmonary fibrosis (IPF) is a deadly disease, largely unresponsive to treatment
with corticosteroids and immunosuppressives. The aim of this randomized, prospective …

[PDF][PDF] Effects of antifibrotic agents on TGF-b1, CTGF and IFN-c expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri… - Respiratory …, 2007 - academia.edu
Idiopathic pulmonary fibrosis (IPF) is a deadly disease, largely unresponsive to treatment
with corticosteroids and immunosuppressives. The aim of this randomized, prospective …

Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri… - 2007 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a deadly disease, largely unresponsive to treatment
with corticosteroids and immunosuppressives. The aim of this randomized, prospective …

Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri… - Respiratory …, 2007 - infona.pl
Idiopathic pulmonary fibrosis (IPF) is a deadly disease, largely unresponsive to treatment
with corticosteroids and immunosuppressives. The aim of this randomized, prospective …

[引用][C] Effects of antifibrotic agents on TGF-[beta] 1, CTGF and IFN-[gamma] expression in patients with idiopathic pulmonary fibrosis

EG Tzortzaki, KM Antoniou, MI Zervou… - Respiratory …, 2007 - Elsevier Limited